CATALOGO DEI PRODOTTI DELLA RICERCA

RIBICHINI, Flavio Luciano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.204
EU - Europa 14.678
AS - Asia 11.757
SA - Sud America 1.737
AF - Africa 419
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 5
Totale 44.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.873
RU - Federazione Russa 6.574
SG - Singapore 5.062
CN - Cina 3.117
GB - Regno Unito 2.451
BR - Brasile 1.377
IT - Italia 1.212
HK - Hong Kong 1.051
VN - Vietnam 1.007
FR - Francia 822
DE - Germania 821
IE - Irlanda 713
SE - Svezia 659
FI - Finlandia 634
KR - Corea 423
UA - Ucraina 214
IN - India 171
CA - Canada 170
BD - Bangladesh 159
AR - Argentina 124
JP - Giappone 109
NL - Olanda 103
MX - Messico 95
ID - Indonesia 93
TR - Turchia 89
ZA - Sudafrica 84
PL - Polonia 79
NG - Nigeria 73
IQ - Iraq 71
ES - Italia 67
TG - Togo 67
EC - Ecuador 59
PK - Pakistan 56
AT - Austria 51
BE - Belgio 51
BJ - Benin 44
CO - Colombia 40
UZ - Uzbekistan 39
VE - Venezuela 39
IR - Iran 34
MA - Marocco 34
SA - Arabia Saudita 33
EG - Egitto 32
PH - Filippine 32
AU - Australia 30
LT - Lituania 28
PY - Paraguay 28
CL - Cile 26
JO - Giordania 26
RO - Romania 26
CZ - Repubblica Ceca 24
AE - Emirati Arabi Uniti 20
PE - Perù 20
TN - Tunisia 20
IL - Israele 19
AZ - Azerbaigian 18
MY - Malesia 18
CH - Svizzera 16
OM - Oman 16
DZ - Algeria 15
GR - Grecia 13
KG - Kirghizistan 13
AL - Albania 11
UY - Uruguay 11
BY - Bielorussia 10
GE - Georgia 10
HU - Ungheria 10
JM - Giamaica 10
KZ - Kazakistan 10
NP - Nepal 10
PA - Panama 10
SI - Slovenia 10
BO - Bolivia 9
PT - Portogallo 9
CR - Costa Rica 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
GT - Guatemala 8
AO - Angola 7
EE - Estonia 7
LB - Libano 7
NO - Norvegia 7
RS - Serbia 7
TH - Thailandia 7
BG - Bulgaria 6
CG - Congo 6
KE - Kenya 6
LV - Lettonia 6
PS - Palestinian Territory 6
CI - Costa d'Avorio 5
ET - Etiopia 5
HR - Croazia 5
MD - Moldavia 5
CY - Cipro 4
GY - Guiana 4
KH - Cambogia 4
LU - Lussemburgo 4
MT - Malta 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
Totale 44.756
Salva come PNG Salva come JPEG
Città #
Singapore 2.662
Moscow 2.183
Ashburn 2.030
Southend 2.004
San Jose 1.653
Jacksonville 1.476
Chandler 1.371
Dallas 1.282
Hong Kong 1.038
Woodbridge 905
Dublin 701
The Dalles 575
Verona 553
Ann Arbor 533
Beijing 533
New York 505
Houston 428
Los Angeles 331
Ho Chi Minh City 329
Lawrence 277
Princeton 277
Munich 254
Wilmington 253
Hanoi 248
Helsinki 225
Jinan 211
Nanjing 163
Shenyang 155
Buffalo 135
Redondo Beach 135
São Paulo 133
Hebei 130
Tianjin 114
Santa Clara 108
Columbus 101
Milan 91
Seattle 91
London 86
Sindelfingen 82
Tokyo 76
Guangzhou 75
Changsha 74
Nanchang 70
Frankfurt am Main 68
Montreal 68
Lomé 66
Washington 66
Orem 65
Zhengzhou 65
Abuja 64
Warsaw 63
Haikou 62
Seoul 62
Rio de Janeiro 58
Atlanta 57
Hangzhou 57
Turku 57
Amsterdam 55
Johannesburg 55
Stockholm 55
Denver 54
Chicago 52
Taizhou 52
Brooklyn 51
Boardman 50
Brussels 49
San Francisco 49
Taiyuan 49
Ningbo 48
Nuremberg 48
Haiphong 47
Chennai 46
Norwalk 46
Cotonou 44
Fuzhou 43
Jiaxing 43
Toronto 43
Council Bluffs 42
Rome 41
Redwood City 37
Baghdad 36
Da Nang 36
Tashkent 35
Phoenix 33
Poplar 33
Belo Horizonte 32
Boston 32
Redmond 32
Fairfield 31
Falkenstein 29
Jakarta 29
Kent 29
Brasília 28
Bologna 27
Lanzhou 27
Shanghai 27
Mexico City 26
Biên Hòa 25
City of London 25
Falls Church 25
Totale 27.230
Salva come PNG Salva come JPEG
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 590
Angiography-Derived and Sensor-Wire Methods to Assess Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction 252
Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 226
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 218
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 213
Accuracy of Micro-Computed Tomography in Post-mortem Evaluation of Fetal Congenital Heart Disease. Comparison Between Post-mortem Micro-CT and Conventional Autopsy 209
[The use of activated clotting time (ACT) to optimize heparinization during coronary angioplasty. The nursing personnel of the Hemodynamics Laboratory]. 206
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 206
[Bypass surgery versus percutaneous coronary intervention: evidence, indications and patient preference according to the latest European guidelines on myocardial revascularization] 206
First successful management of aortic valve insufficiency associated with HeartMate II left ventricular assist device support by transfemoral CoreValve implantation: the Columbus's egg? 205
A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale. 204
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 204
[Emergency angioplasty in high-risk acute infarct]. 197
[Analysis of right electrocardiographic leads in 195 normal subjects]. 194
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 193
[Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct]. 191
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 191
Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity 190
Effects of Aortic Valve Replacement on Left Ventricular Diastolic Function in Patients With Aortic Valve Stenosis 190
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. 187
Drug-coated balloon: Long-term outcome from a real world three-center experience 187
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 186
Hemodynamic predictors of long term survival in end stage cystic fibrosis 186
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 186
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 184
Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization 184
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. 183
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 183
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 181
A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease: The EXECUTIVE Trial (EXecutive RCT: Evaluating XIENCE V in a Multi Vessel Disease). 181
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis 178
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI 177
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 177
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 177
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 176
[Heart catheterization via the femoral artery with a 4 French and mobilization at 2 hours]. 175
[Radiologic practice and radioprotection in Italian hemodynamic laboratories]. 174
In-stent restenosis. 173
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 173
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 172
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives 172
Usefulness of Left Atrial Remodeling in Predicting CardiacToxicity During Trastuzumab Therapy for Breast Cancer 172
Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to and Support for Pulmonary Thromboendarterectomy in Misdiagnosed Chronic Thromboembolic Pulmonary Hypertension 172
[Elective coronary angioplasty in total absence of heart surgery]. 171
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 171
Early functional and structural changes of the left atrium in a patient with trastuzumab: related cardiotoxicity 171
Clinical impact of mitral regurgitation in aortic valve stenosis: Insight from effective regurgitant orifice area 170
[Invasive cardiological diagnosis in an ambulatory regimen of transported inpatients]. 169
Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis 169
[Primary angioplasty in acute inferior myocardial infarct with anterior ST-segment depression: the long-term follow-up]. 168
[Technical features of Absorb(TM) BVS implantation in the IT-DISAPPEARS registry] 168
The Common Combination of Aortic Stenosis with Mitral Regurgitation: Diagnostic Insight and Therapeutic Implications in the Modern Era of Advanced Echocardiography and Percutaneous Intervention 168
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 167
Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial 165
Elective coronary angioplasty with and without surgical standby: clinical and angiographic criteria for the selection of patients. 164
Optimizing the role of transthoracic echocardiography to improve the cardiovascular risk stratification: the dream of subclinical coronary artery disease detection 164
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 164
Midventricular Takotsubo cardiomyopathy complicated by a ventricular septal rupture: a surgical management 163
Coronary artery disease in patients undergoing transcatheter aortic valve implantation. A single centre registry on prevalence, management and immediate clinical impact 162
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 161
Impella-protected PCI: the clinical results achieved so far 161
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 161
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. 161
Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy 160
[Diagnostic hemodynamics in day-hospital care]. 159
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 159
First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm 158
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 158
Intravascular ultrasound assessment of coronary ostia following valve in valve transcatheter aortic valve implantation 158
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 157
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 156
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 156
Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients 155
Excess mortality associated with progression rate in asymptomatic aortic valve stenosis 155
[Quality assurance and cost control in invasive and interventional cardiology]. 154
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI 154
Early atrial fibrillation detection is associated with higher arrhythmic burden in patients with loop recorder after an embolic stroke of undetermined source 153
Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study 151
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 150
Impact of ultra-thin struts on restenosis after chronic total occlusion recanalization: Insights from the randomized PRISON IV trial 149
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 149
Angiography-derived index of microvascular resistance in takotsubo syndrome 149
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation 148
On-line quantitative coronary analysis in clinical practice: one step closer to reality? 148
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 147
Angiotensin antagonism in coronary artery disease: results after coronary revascularisation. 147
Bioresorbable vascular scaffolds in cardiac allograft vasculopathy: a new therapeutic option. 147
Functional mitral regurgitation: are we treating the real target? 147
Role of Speckle Tracking Echocardiography in the Evaluation of Breast Cancer Patients Undergoing Chemotherapy: Review and Meta-analysis of the Literature 147
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy 147
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy 146
On the current epidemic outburst of meta-analytic rage in interventional cardiology. 146
Concomitant myocardial infarction in identical twins with similar coronary lesions. 146
Correlation between epicardial adipose tissue and atrial fibrillation burden in coronary artery bypass graft surgery 145
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries 145
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 145
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 144
Long-term variations of FFR and iFR after transcatheter aortic valve implantation 144
New-onset extreme right axis deviation in acute myocardial infarction: clinical characteristics and outcomes 144
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). 143
Totale 17.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.938
article - articoli 162.938
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 325.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/20221.722 171 350 15 103 80 47 25 107 67 71 185 501
2022/20234.309 319 454 450 643 351 1.040 91 284 478 22 108 69
2023/20242.862 87 197 277 305 313 595 134 214 23 170 375 172
2024/20257.228 370 414 237 1.182 378 277 353 363 1.186 573 597 1.298
2025/202620.897 1.592 996 1.464 3.633 5.421 1.444 1.963 1.175 1.687 1.035 391 96
Totale 45.176